These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 20147776)

  • 1. Resonant activation: a strategy against bacterial persistence.
    Fu Y; Zhu M; Xing J
    Phys Biol; 2010 Feb; 7(1):16013. PubMed ID: 20147776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incorporating toxin hypothesis into a mathematical model of persister formation and dynamics.
    Cogan NG
    J Theor Biol; 2007 Sep; 248(2):340-9. PubMed ID: 17585944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibiotic treatment in vitro of phenotypically tolerant bacterial populations.
    Wiuff C; Andersson DI
    J Antimicrob Chemother; 2007 Feb; 59(2):254-63. PubMed ID: 17105735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biofilms and antibiotic therapy: is there a role for combating bacterial resistance by the use of novel drug delivery systems?
    Smith AW
    Adv Drug Deliv Rev; 2005 Jul; 57(10):1539-50. PubMed ID: 15950314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The importance of being persistent: heterogeneity of bacterial populations under antibiotic stress.
    Gefen O; Balaban NQ
    FEMS Microbiol Rev; 2009 Jul; 33(4):704-17. PubMed ID: 19207742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of persister formation on bacterial response to dosing.
    Cogan NG
    J Theor Biol; 2006 Feb; 238(3):694-703. PubMed ID: 16125727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evolution of antibiotic resistance by human and bacterial niche construction.
    Boni MF; Feldman MW
    Evolution; 2005 Mar; 59(3):477-91. PubMed ID: 15856691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A network-based approach for resistance transmission in bacterial populations.
    Gehring R; Schumm P; Youssef M; Scoglio C
    J Theor Biol; 2010 Jan; 262(1):97-106. PubMed ID: 19747924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New-found fundamentals of bacterial persistence.
    Kint CI; Verstraeten N; Fauvart M; Michiels J
    Trends Microbiol; 2012 Dec; 20(12):577-85. PubMed ID: 22959615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Persisters and beyond: mechanisms of phenotypic drug resistance and drug tolerance in bacteria.
    Kester JC; Fortune SM
    Crit Rev Biochem Mol Biol; 2014; 49(2):91-101. PubMed ID: 24328927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A molecular model for persister in E. coli.
    Lou C; Li Z; Ouyang Q
    J Theor Biol; 2008 Nov; 255(2):205-9. PubMed ID: 18721814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simple models of antibiotic cycling.
    Reluga TC
    Math Med Biol; 2005 Jun; 22(2):187-208. PubMed ID: 15778333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combating bacteria and drug resistance by inhibiting mechanisms of persistence and adaptation.
    Smith PA; Romesberg FE
    Nat Chem Biol; 2007 Sep; 3(9):549-56. PubMed ID: 17710101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What's new on the antimicrobial horizon?
    Song JH
    Int J Antimicrob Agents; 2008 Dec; 32 Suppl 4():S207-13. PubMed ID: 19134521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The challenge of treating biofilm-associated bacterial infections.
    del Pozo JL; Patel R
    Clin Pharmacol Ther; 2007 Aug; 82(2):204-9. PubMed ID: 17538551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formation, physiology, ecology, evolution and clinical importance of bacterial persisters.
    Van den Bergh B; Fauvart M; Michiels J
    FEMS Microbiol Rev; 2017 May; 41(3):219-251. PubMed ID: 28333307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Persistent and susceptible bacteria with individual deaths.
    Zucca F
    J Theor Biol; 2014 Feb; 343():69-78. PubMed ID: 24270094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bacterial resistance to antibiotics: active efflux and reduced uptake.
    Kumar A; Schweizer HP
    Adv Drug Deliv Rev; 2005 Jul; 57(10):1486-513. PubMed ID: 15939505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bacterial persisters tolerate antibiotics by not producing hydroxyl radicals.
    Kim JS; Heo P; Yang TJ; Lee KS; Jin YS; Kim SK; Shin D; Kweon DH
    Biochem Biophys Res Commun; 2011 Sep; 413(1):105-10. PubMed ID: 21872573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.